Binance Coin Eyes Record Highs as Windtree Therapeutics Bets Big on BNB

BNB is back in the spotlight, and this time, it’s not just crypto traders who are paying attention. The token brushed $800 on Sunday, clocking up 7% gains over three straight days — and things are heating up fast.

Fuelled by a jaw-dropping $520 million move from Nasdaq-listed Windtree Therapeutics, BNB looks primed to break through its previous all-time highs. Analysts now have their eyes firmly set on the $818–$820 range, with Bollinger Bands flashing signs of serious momentum.

Windtree’s Corporate Treasury Surprise

The biotech firm Windtree Therapeutics stunned investors late last week with a corporate treasury play that’s anything but conventional.

Just days after announcing a $500 million equity line of credit and a $20 million stock purchase agreement, Windtree made clear its intentions: 99% of that capital is earmarked for Binance Coin.

One sentence, but big impact.

Investors were caught off guard — not just by the size of the proposed BNB acquisition, but by the timing. The move comes at a time when many institutional players are still cautiously weighing up crypto risks. Windtree? They’re already writing the cheques.

Bollinger Bands Point to Next Resistance at $818

Technically, BNB is showing signs of a breakout.

The Bollinger Bands — a volatility indicator that envelopes the price chart — have started to widen. That typically happens when trading volume picks up and price action gets more aggressive. It’s exactly what we’re seeing now.

Here’s why that matters:

• A widening Bollinger Band often suggests sustained price moves in either direction.

• In this case, BNB’s price is hugging the upper band, indicating upward momentum.

• Analysts are pinpointing $818 as the next serious resistance level.

If price breaks that? We could be staring at a new all-time high by mid-week.

The Numbers Behind the Rally

Let’s put the move into perspective. Here’s a look at what’s driving BNB’s momentum this month:

That $800 psychological level? It’s not just round-number optimism — it’s a marker that large players often watch. When crossed with conviction, it often acts as a launchpad.

Big Business Is Going Crypto — Quietly, but Surely

This isn’t just about BNB or Binance.

Windtree’s announcement adds to a slow-burning trend. More public companies are dipping their toes into digital assets. From Tesla’s Bitcoin buy to MicroStrategy’s BTC obsession, the tide is turning — cautiously, but deliberately.

Jed Latkin, Windtree’s CEO, said the move is aimed at “strengthening our digital asset position”. That might sound buzzwordy, but the financial commitment is real. A $520 million strategy doesn’t happen without conviction.

And it’s not isolated. Since January, at least four other public companies in the U.S. and South Korea have disclosed crypto holdings, with a combined exposure of over $2 billion.

Traders Brace for Impact — Bullish or Bearish?

Sentiment across BNB-focused trading forums and crypto Twitter feels oddly calm, but the charts suggest otherwise.

One sentence here too.

We’re seeing a rise in open interest on Binance futures, while funding rates stay relatively flat — a sign that the rally may not yet be overheated. Meanwhile, whale wallets (those holding over 10,000 BNB) have grown by 4.2% in the last two weeks, based on Lookonchain data.

That doesn’t guarantee anything, but it tells us this: big money is accumulating.

Still, risk remains. A failed breakout at $818 could see BNB retreat back to the $760–$770 support band, erasing recent gains and cooling sentiment.

All Eyes on the Shareholder Vote

For Windtree, it’s not a done deal yet.

The proposed BNB acquisition still needs shareholder approval. The vote is expected next week, and it’s already drawing scrutiny. Some analysts argue it’s too risky for a mid-sized biotech firm. Others see it as visionary — a bold diversification play that could redefine treasury strategy.

Either way, it’s stirring up conversation.

If the vote passes, Windtree becomes one of the largest public holders of BNB globally. That’s not a headline most expected from a biotech firm with no direct links to crypto.